Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
MA-EL RX from Braine-l'Alleud, company number BE0859704565, closed financial year 2025 with a result of € 110,203 after tax. For that financial year MA-EL RX recorded a gross margin of € 187,193 and equity of € 505,519. Compared with financial year 2024, the result moved from € 74,181 to € 110,203. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 13, 2026.
€ 505,519
▲ 20% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 110,203
▲ 49% vs 2024
Profit after tax over the fiscal year.
€ 121,812
▼ 33% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 27,448 paid out
25 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
0.2
Average over the fiscal year, from the social balance sheet.
€ 11,941
▲ 1% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,607
▲ 94% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1,399
▼ 87% vs 2024
Loans from banks and other lenders, long and short.
€ 18,830
▲ € 15,988 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 38,185
▲ 265% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 117,257 | € 292,446 | € 143,732 | € 187,193 | ▲ 30% |
| Profit after taxes | € 49,449 | € 169,819 | € 74,181 | € 110,203 | ▲ 49% |
| Equity | € 207,778 | € 376,797 | € 422,764 | € 505,519 | ▲ 20% |
| Total debts | € 116,903 | € 137,255 | € 29,377 | € 70,059 | ▲ 138% |
| Cash | € 9,785 | € 206,841 | € 180,979 | € 121,812 | ▼ 33% |
| Retained profit | € 195,378 | € 364,397 | € 410,364 | € 493,119 | ▲ 20% |
| Dividend | € 800 | € 800 | € 28,215 | € 27,448 | ▼ 3% |
| Bank debt | € 55,575 | € 36,236 | € 11,009 | € 1,399 | ▼ 87% |
| Balance sheet total | € 324,681 | € 514,052 | € 452,141 | € 575,579 | ▲ 27% |
| Employees (FTE) | - | 0.2 | 0.2 | 0.2 |
Key figures of MA-EL RX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MA-EL RX?
What happened at MA-EL RX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 110,203 (▲ 49% vs 2024). Source: NBB ↗
- Marie LORENT became a director. NBB
- Béatrice BOUCHE became a director. NBB
- New establishment in Schaarbeek. KBO
- Start of the company according to the CBE. KBO
In short
From € 49,449 profit in 2022 to € 110,203 profit in 2025.
Paid € 200,051 in corporate taxes since 2022.
Best year ever: 2023, with € 169,819 profit.
Paid out € 57,263 in dividends to the owners in total.
A new publication or filing at MA-EL RX? We notify you, reason included.
Follow MA-EL RXDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind MA-EL RX are Marie LORENT and Béatrice BOUCHE. It owns 33% of centre de radiodiagnostic medicis itself.
Directors
According to the 2025 annual accounts
Marie LORENT
Director
since 2025
since 2003
Establishments
Establishment units
Physical locations of this company
Av la Douce Colline 22
1420 Braine-l'Alleud
Leopold III-laan 5
1030 Schaarbeek
Active since 16 June 2003
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0859.704.565
- VAT number
- BE 0859.704.565
- Registered office
- Av la Douce Colline 22, 1420 Braine-l'Alleud
- Names & denominations
- MA-EL RX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 June 2003
- Peppol
- Not registered
- Activities · NACE
Activiteiten van medisch specialisten